$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2014 Q2 Form 10-Q Financial Statement

#000156459014003557 Filed on August 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $43.75K $43.75K
YoY Change 0.0% -8.7%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.080M $2.040M
YoY Change 198.04% -60.84%
% of Gross Profit
Research & Development $6.392M $1.757M
YoY Change 263.91% 44.07%
% of Gross Profit
Depreciation & Amortization $276.1K $454.1K
YoY Change -39.21% 7.24%
% of Gross Profit
Operating Expenses $12.74M $6.434M
YoY Change 98.08% -6.09%
Operating Profit -$12.70M -$6.390M
YoY Change 98.75% -6.07%
Interest Expense $226.4K -$10.00K
YoY Change -2364.24% -101.11%
% of Operating Profit
Other Income/Expense, Net $1.074M $212.2K
YoY Change 405.87% -114.77%
Pretax Income -$11.63M -$6.178M
YoY Change 88.2% -25.03%
Income Tax
% Of Pretax Income
Net Earnings -$11.63M -$6.079M
YoY Change 91.26% -23.93%
Net Earnings / Revenue -26575.81% -13894.88%
Basic Earnings Per Share
Diluted Earnings Per Share -$224.0K -$232.7K
COMMON SHARES
Basic Shares Outstanding 31.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $188.5M $33.10M
YoY Change 469.39% 1279.17%
Cash & Equivalents $138.3M $29.03M
Short-Term Investments $50.12M $4.100M
Other Short-Term Assets $1.200M $1.100M
YoY Change 9.09% 175.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $300.0K
Total Short-Term Assets $163.4M $34.41M
YoY Change 374.85% 483.24%
LONG-TERM ASSETS
Property, Plant & Equipment $3.700M $3.793M
YoY Change -2.46% -29.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $26.30M $0.00
YoY Change -100.0%
Other Assets $0.00 $3.284M
YoY Change -100.0%
Total Long-Term Assets $33.20M $7.077M
YoY Change 369.09% -33.23%
TOTAL ASSETS
Total Short-Term Assets $163.4M $34.41M
Total Long-Term Assets $33.20M $7.077M
Total Assets $196.6M $41.49M
YoY Change 373.87% 151.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $1.062M
YoY Change 107.17% 6.19%
Accrued Expenses $1.700M $706.1K
YoY Change 140.76% -66.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $1.100M
YoY Change -72.73% 450.0%
Total Short-Term Liabilities $8.300M $6.678M
YoY Change 24.29% 15.14%
LONG-TERM LIABILITIES
Long-Term Debt $800.0K $1.200M
YoY Change -33.33% -42.86%
Other Long-Term Liabilities $1.800M $337.6K
YoY Change 433.2% 237.59%
Total Long-Term Liabilities $2.600M $1.505M
YoY Change 72.8% -31.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.300M $6.678M
Total Long-Term Liabilities $2.600M $1.505M
Total Liabilities $10.30M $8.183M
YoY Change 25.88% 15.25%
SHAREHOLDERS EQUITY
Retained Earnings -$152.4M
YoY Change
Common Stock $187.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $186.4M $34.96M
YoY Change
Total Liabilities & Shareholders Equity $196.6M $41.49M
YoY Change 373.87% 151.45%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$11.63M -$6.079M
YoY Change 91.26% -23.93%
Depreciation, Depletion And Amortization $276.1K $454.1K
YoY Change -39.21% 7.24%
Cash From Operating Activities -$9.800M -$5.300M
YoY Change 84.91% 35.9%
INVESTING ACTIVITIES
Capital Expenditures -$700.0K -$200.0K
YoY Change 250.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $1.600M -$4.100M
YoY Change -139.02% -4200.0%
Cash From Investing Activities $1.000M -$4.300M
YoY Change -123.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $35.40M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.400M 35.30M
YoY Change -87.54% 1207.41%
NET CHANGE
Cash From Operating Activities -9.800M -5.300M
Cash From Investing Activities 1.000M -4.300M
Cash From Financing Activities 4.400M 35.30M
Net Change In Cash -4.400M 25.70M
YoY Change -117.12% -2241.67%
FREE CASH FLOW
Cash From Operating Activities -$9.800M -$5.300M
Capital Expenditures -$700.0K -$200.0K
Free Cash Flow -$9.100M -$5.100M
YoY Change 78.43% 34.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
4018719
CY2013Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
4096363
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3758264
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
257178
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
160495
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6392200
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1756527
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14719739
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2038682
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
276054
CY2013Q2 arwr Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
1308047
arwr Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
1308047
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-380699
CY2014Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
226424
CY2013Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-48252
CY2013Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6177628
CY2014Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2014Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-11626451
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
172641720
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
42448824
arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
12374005
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-354
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-11626451
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-6177628
us-gaap Profit Loss
ProfitLoss
-36294880
us-gaap Profit Loss
ProfitLoss
-17898373
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2468
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-98618
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-95132
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-447268
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-11628919
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-6079010
us-gaap Net Income Loss
NetIncomeLoss
-36199748
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51931989
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18893197
arwr Warrants Exercised During Period Value
WarrantsExercisedDuringPeriodValue
10004793
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2369262
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
5789979
us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1303911
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-354
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
416292
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
82341
us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
87197
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2315721
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-75000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-9375
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
517986
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1080
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
127248
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
441373
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11402
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1813
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
990929
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
183959
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
459690
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
95132
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4480
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-313354
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24496567
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13639360
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1251987
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
191656
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
89505
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
46365528
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4058003
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6590824
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1160181
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-41026691
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2999973
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
184758547
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
42288329
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-354
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-354
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
119235289
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25648642
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3377288
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29025930
us-gaap Interest Paid
InterestPaid
21478
us-gaap Interest Paid
InterestPaid
32139
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains several checking accounts for its operations at two financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per account. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p></div>
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates&#8212;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Actual results could differ from those estimates.&nbsp;&nbsp;</p></div>
us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
less than 27 months
arwr Net Cash Invested In Fixed Income Investments
NetCashInvestedInFixedIncomeInvestments
39800000
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2014Q2 arwr Cost Method Investment Attributable To Noncontrolling Interest
CostMethodInvestmentAttributableToNoncontrollingInterest
0
CY2014Q2 arwr Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
5749
CY2014Q2 arwr Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
389403
CY2014Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
49735616
CY2014Q2 us-gaap Marketable Securities
MarketableSecurities
50119270
CY2013Q3 arwr Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
7500
CY2013Q3 arwr Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
41643
CY2013Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
10698271
CY2013Q3 us-gaap Marketable Securities
MarketableSecurities
10732414
CY2014Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
334162
CY2013Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
323376
CY2014Q2 arwr Research Equipment
ResearchEquipment
4248606
CY2013Q3 arwr Research Equipment
ResearchEquipment
3452013
CY2014Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
69623
CY2013Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
69623
CY2014Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2955217
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2749409
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7607608
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6594421
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3933477
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3081186
arwr Obligation To Pay Royalties
ObligationToPayRoyalties
later of (i) the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii) ten years after the first commercial sale of such product candidate.
CY2011Q4 arwr Present Value Of Contingent Acquisition Consideration
PresentValueOfContingentAcquisitionConsideration
84935
CY2013 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1400000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
14000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
55000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
0
CY2012Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
CY2013 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
CY2013 arwr Indefinite Lived Intangible Assets Amortization
IndefiniteLivedIntangibleAssetsAmortization
CY2013Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
arwr Indefinite Lived Intangible Assets Amortization
IndefiniteLivedIntangibleAssetsAmortization
CY2014Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
CY2012Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1667247
CY2013 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1308047
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123191
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40990
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
82201
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4784569
arwr Ownership Percentage In Subsidiary
OwnershipPercentageInSubsidiary
1.00
CY2014Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3071672
CY2013Q4 arwr Conversion Price Per Share
ConversionPricePerShare
5.86
CY2013Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
60000000
CY2013Q4 arwr Aggregate Price On Issuance Or Sale Of Equity
AggregatePriceOnIssuanceOrSaleOfEquity
64000000
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6325000
CY2014Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.95
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
112600000
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1526781
arwr Other Rental Expenses
OtherRentalExpenses
16000
us-gaap Utilities Costs
UtilitiesCosts
15000
CY2014Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
410085
arwr Share Based Compensation Arrangement By Share Based Payment Award Inducement Grants
ShareBasedCompensationArrangementByShareBasedPaymentAwardInducementGrants
165000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
930000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
148561
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
377112
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1532180
arwr Increase In Monthly Expenditure Due To Utilities Costs
IncreaseInMonthlyExpenditureDueToUtilitiesCosts
75000
arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
403000
CY2013Q2 arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
126000
arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
407000
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
57105
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
228420
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
228420
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
228420
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
228420
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
95175
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
40681
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
1025279
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
134164
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
580626
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
597196
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
613984
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
638217
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
432861
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2997048
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.03
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.93
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.88
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.28
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30271011
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13666712
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1070631
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2186653
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
363593
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1114375
CY2014Q2 arwr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
1176000
arwr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
8295600
CY2013Q2 arwr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
1094295
arwr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
1197588
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
371334
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3606061
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.26
CY2012Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
173621
CY2012Q3 arwr Business Combination Purchase Price Contingent Consideration Fair Value
BusinessCombinationPurchasePriceContingentConsiderationFairValue
CY2012Q3 arwr Business Combination Contingent Consideration Payments
BusinessCombinationContingentConsiderationPayments
CY2012Q3 arwr Business Combination Fair Value Of Change In Contingent Consideration
BusinessCombinationFairValueOfChangeInContingentConsideration
1421652
CY2013Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1595273
CY2014Q2 arwr Business Combination Purchase Price Contingent Consideration Fair Value
BusinessCombinationPurchasePriceContingentConsiderationFairValue
CY2014Q2 arwr Business Combination Contingent Consideration Payments
BusinessCombinationContingentConsiderationPayments
CY2014Q2 arwr Business Combination Fair Value Of Change In Contingent Consideration
BusinessCombinationFairValueOfChangeInContingentConsideration
CY2014Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1595273

Files In Submission

Name View Source Status
0001564590-14-003557-index-headers.html Edgar Link pending
0001564590-14-003557-index.html Edgar Link pending
0001564590-14-003557.txt Edgar Link pending
0001564590-14-003557-xbrl.zip Edgar Link pending
arwr-10q_20140630.htm Edgar Link pending
arwr-20140630.xml Edgar Link completed
arwr-20140630.xsd Edgar Link pending
arwr-20140630_cal.xml Edgar Link unprocessable
arwr-20140630_def.xml Edgar Link unprocessable
arwr-20140630_lab.xml Edgar Link unprocessable
arwr-20140630_pre.xml Edgar Link unprocessable
arwr-ex10_20140630353.htm Edgar Link pending
arwr-ex31_201406306.htm Edgar Link pending
arwr-ex31_201406307.htm Edgar Link pending
arwr-ex32_201406308.htm Edgar Link pending
arwr-ex32_201406309.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending